NIBRT is looking to procure an automated multiplexed bioreactor platform to support early-stage small scale cell culture activities to support clone selection, media and feed optimisation and process intensification for monoclonal antibodies, recombinant proteins, and advanced therapies such as viral vectors for gene therapy and cell therapy development. The desired solution should be contained in a biological safety cabinet, ideally BLS2, and should enable autonomous operation, ideally facilitating statistically valid design of experiment optimisation to be performed. Each bioreactor should be independently controlled. The proposed solution should also have capability for direct integration with analytical solutions, such as cell counters, nutrient and bolite analysers and other analytical instrumentation, e.g., spectroscopic instruments.